Medilax

Lactulose, the active ingredient in Medilax, is an osmotic laxative presented as an oral formulation for oral use. It is employed to relieve constipation and to manage hepatic encephalopathy by lowering intestinal ammonia levels in adult patients. It works by increasing osmotic pressure in the intestinal lumen, drawing water into the colon to facilitate bowel movements.

GNH USA supplies Medilax as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to European Union quality standards and provides reliable sourcing for healthcare providers across multiple regions.

Lactulose is used to treat conditions related to bowel motility and ammonia accumulation.

- Constipation: Relieves infrequent or difficult bowel movements by softening stools and increasing stool frequency. - Hepatic encephalopathy: Reduces blood ammonia levels, helping to prevent or treat episodes of neuropsychiatric disturbance in patients with liver disease. - Portal‑systemic encephalopathy: Supports long‑term control of neurocognitive symptoms in cirrhotic patients.

Lactulose may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Flatulence: Excess gas production due to bacterial fermentation. - Abdominal cramping: Stomach discomfort from increased intestinal activity. - Diarrhea: Loose stools when the osmotic effect is pronounced. - Nausea: Mild queasiness after ingestion. - Bloating: Sensation of fullness in the abdomen. - Electrolyte imbalance: Minor changes in sodium or potassium levels.

Serious or Rare Side Effects: - Severe dehydration: Excessive fluid loss requiring medical attention. - Marked electrolyte disturbances: Significant shifts in sodium, potassium, or calcium. - Allergic reaction: Rash, itching, or swelling indicating hypersensitivity. - Persistent abdominal pain: May signal an underlying gastrointestinal issue.

Before using Medilax, certain safety considerations should be observed.

- Assess renal function: Adjust use in patients with impaired kidney function. - Monitor electrolytes: Watch for sodium and potassium changes during therapy. - Avoid abrupt dose increase: Titrate gradually to minimize gastrointestinal upset. - Use with caution in diabetics: Lactulose solutions contain sugars that may affect glucose control. - Pregnancy and lactation: Consult a healthcare professional before use. - Store at ambient temperature: Keep in the original container, protect from moisture and heat.

Lactulose can interact with other medicines, requiring attention to avoid reduced efficacy or increased risk.

Major Interactions (Avoid): - Antibiotics (e.g., neomycin): May diminish lactulose's effect on ammonia reduction. - Magnesium‑containing laxatives: Heighten risk of electrolyte loss and diarrhea. - Loop or thiazide diuretics: Increase potential for dehydration and electrolyte disturbances.

Moderate Interactions (Monitor Closely): - Antacids: May alter colonic pH and affect lactulose activity. - Probiotics: Could modify gut flora and influence drug metabolism. - Oral hypoglycemic agents: Monitor blood glucose as lactulose may affect carbohydrate absorption.